Attached files
| file | filename |
|---|---|
| 10-Q/A - 10-Q/A - Karyopharm Therapeutics Inc. | a14-24505_110qa.htm |
| EX-31.1 - EX-31.1 - Karyopharm Therapeutics Inc. | a14-24505_1ex31d1.htm |
Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO RULE 13a-14(a)/15d-14(a) PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
I, Justin A. Renz, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q/A (Amendment No. 1) of Karyopharm Therapeutics Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
|
/s/ Justin A. Renz |
|
|
Justin A. Renz |
|
|
Executive Vice President and Chief Financial Officer |
|
|
(Principal financial and accounting officer) |
Date: November 14, 2014